These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. A panel-based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration-resistant prostate cancer. Boiarsky D; Tewari AK; Gulhan DC; Bakouny Z; Ananda G; Savignano H; Lakshminarayanan G; McClure HM; Silver R; Choueiri TK; Taplin ME; Park PJ; Berchuck JE Prostate; 2024 Dec; 84(16):1479-1489. PubMed ID: 39252459 [TBL] [Abstract][Full Text] [Related]
31. The Great Majority of Homologous Recombination Repair-Deficient Tumors Are Accounted for by Established Causes. Štancl P; Hamel N; Sigel KM; Foulkes WD; Karlić R; Polak P Front Genet; 2022; 13():852159. PubMed ID: 35783256 [No Abstract] [Full Text] [Related]
32. Homologous Recombination Deficiency Unrelated to Platinum and PARP Inhibitor Response in Cell Line Libraries. Takamatsu S; Murakami K; Matsumura N Sci Data; 2024 Feb; 11(1):171. PubMed ID: 38321018 [TBL] [Abstract][Full Text] [Related]
33. Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort. Leibowitz BD; Dougherty BV; Bell JSK; Kapilivsky J; Michuda J; Sedgewick AJ; Munson WA; Chandra TA; Dry JR; Beaubier N; Igartua C; Taxter T BMC Cancer; 2022 May; 22(1):587. PubMed ID: 35643464 [TBL] [Abstract][Full Text] [Related]
34. Templated Insertions Are Associated Specifically with BRCA2 Deficiency and Overall Survival in Advanced Ovarian Cancer. Moore G; Majumdar R; Powell SN; Khan AJ; Weinhold N; Yin S; Higginson DS Mol Cancer Res; 2022 Jul; 20(7):1061-1070. PubMed ID: 35385581 [TBL] [Abstract][Full Text] [Related]
35. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types. Takamatsu S; Brown JB; Yamaguchi K; Hamanishi J; Yamanoi K; Takaya H; Kaneyasu T; Mori S; Mandai M; Matsumura N JCO Precis Oncol; 2022 May; 6():e2200085. PubMed ID: 35613413 [TBL] [Abstract][Full Text] [Related]
36. RAD51-Mediated DNA Homologous Recombination Is Independent of Sinha A; Saleh A; Endersby R; Yuan SH; Chokshi CR; Brown KR; Kuzio B; Kauppinen T; Singh SK; Baker SJ; McKinnon PJ; Katyal S Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33138032 [TBL] [Abstract][Full Text] [Related]
37. Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes. da Costa AABA; do Canto LM; Larsen SJ; Ribeiro ARG; Stecca CE; Petersen AH; Aagaard MM; de Brot L; Baumbach J; Baiocchi G; Achatz MI; Rogatto SR BMC Cancer; 2019 May; 19(1):422. PubMed ID: 31060523 [TBL] [Abstract][Full Text] [Related]
38. Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs. Marquard AM; Eklund AC; Joshi T; Krzystanek M; Favero F; Wang ZC; Richardson AL; Silver DP; Szallasi Z; Birkbak NJ Biomark Res; 2015; 3():9. PubMed ID: 26015868 [TBL] [Abstract][Full Text] [Related]
39. BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. Petrelli A; Rizzolio S; Pietrantonio F; Bellomo SE; Benelli M; De Cecco L; Romagnoli D; Berrino E; Orrù C; Ribisi S; Moya-Rull D; Migliore C; Conticelli D; Maina IM; Puliga E; Serra V; Pellegrino B; Llop-Guevara A; Musolino A; Siena S; Sartore-Bianchi A; Prisciandaro M; Morano F; Antista M; Fumagalli U; De Manzoni G; Degiuli M; Baiocchi GL; Amisano MF; Ferrero A; Marchiò C; Corso S; Giordano S Cancer Res; 2023 May; 83(10):1699-1710. PubMed ID: 37129948 [TBL] [Abstract][Full Text] [Related]
40. Copy number alteration features in pan-cancer homologous recombination deficiency prediction and biology. Yao H; Li H; Wang J; Wu T; Ning W; Diao K; Wu C; Wang G; Tao Z; Zhao X; Chen J; Sun X; Liu XS Commun Biol; 2023 May; 6(1):527. PubMed ID: 37193789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]